Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Which CVC dressing securement helps prevent MARSI best

Official title: Effect of Medical Adhesive and Skin Barrier Products Used for Central Venous Catheter Dressings on the Development of Medical Adhesive-Related Skin Injury: A Randomized Controlled Trial

Run by Ege University · NCT07697430 · Data updated 2026-11-12

This study tests three dressing strategies (acrylic tape, silicone tape, and barrier film with acrylic tape) to see which best prevents MARSI in adults with central venous catheters.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment162 (estimated)
SponsorEge University
Academic / other
Locations1 site (Afyonkarahisar, Center)
StatusRecruiting
StartedJune 1, 2026
Main results expectedJune 1, 2027
Study endsJune 1, 2027
Registry record updatedJuly 21, 2026
Trial IDNCT07697430 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with an upcoming non-tunneled internal jugular CVC placement in the chest ICU or operating room.

Probably not a fit

Patients who do not develop MARSI may not experience a direct benefit beyond standard care.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this prospective, single-center study, adults requiring non-tunneled internal jugular CVCs in a chest ICU setting will be randomized to one of three dressing securement strategies. Participants will have regular skin assessments for MARSI over up to 21 days or until catheter removal. The trial aims to identify which method most effectively reduces skin injury from adhesives while maintaining catheter security. Safety and adverse skin reactions will be monitored as part of standard clinical care. Results could guide best practices for preventing MARSI in ICU patients with CVCs.

Why it matters

Potential benefit: If successful, the preferred dressing securement could reduce MARSI, improve skin integrity, and lower additional care needs and costs.

How similar studies have gone: Previous observational studies exist but high-quality comparative evidence is limited; this study seeks to provide more robust guidance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years or older.
* Patients scheduled to undergo insertion of a non-tunneled central venous catheter via the internal jugular vein in the chest intensive care unit or operating room.
* Patients who provide written informed consent to participate in the study, either personally or through their legally authorized representative.
* Patients with intact skin and no pre-existing skin condition at the catheter insertion site.

Exclusion Criteria:

* Patients with an active or congenital dermatological disease.
* Patients with a known history of allergic reactions to any of the securement products used in the study (medical adhesive tapes or protective barrier film).
* Patients with clinically significant hyperhidrosis (excessive sweating).
* Patients whose central venous catheter is inserted through a site other than the internal jugular vein (e.g., subclavian or femoral vein).
* Patients requiring contact isolation because of an infectious disease (e.g., scabies) or airborne isolation because of a contagious disease (e.g., tuberculosis).

Where it's running

  • Afyonkarahisar Health Sciences University Health Practice and Research Center
    Afyonkarahisar, Center, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.